S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
SHOCKING Crypto Leak… (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The “Perfect Storm” for Gold (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Biden replacement revealed? (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
SHOCKING Crypto Leak… (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The “Perfect Storm” for Gold (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Biden replacement revealed? (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
SHOCKING Crypto Leak… (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The “Perfect Storm” for Gold (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Biden replacement revealed? (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
SHOCKING Crypto Leak… (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The “Perfect Storm” for Gold (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Biden replacement revealed? (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
Free Trial
OTCMKTS:IMUC

EOM Pharmaceuticals (IMUC) Stock Price, News & Analysis

→ Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad)
Free IMUC Stock Alerts
$0.18
+0.03 (+20.55%)
(As of 04/18/2024 ET)
Compare
Today's Range
$0.18
▼
$0.20
50-Day Range
$0.11
▼
$0.30
52-Week Range
$0.11
▼
$0.40
Volume
297 shs
Average Volume
3,950 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest
IMUC stock logo

About EOM Pharmaceuticals Stock (OTCMKTS:IMUC)

Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. Immunocellular Therapeutics, Ltd. was founded in 2020 and is headquartered in Montvale, New Jersey.

IMUC Stock Price History

IMUC Stock News Headlines

January 5, 2024 | uk.finance.yahoo.com
ImmunoCellular Therapeutics, Ltd. (IMUC)
December 29, 2023 | wsj.com
EOM Pharmaceutical Holdings Inc.
April 18, 2024 | Paradigm Press (Ad)
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
November 7, 2023 | finance.yahoo.com
EOM Pharmaceutical Holdings Provides an Update on its Lead Drug Candidate EOM613
November 4, 2023 | markets.businessinsider.com
IZERVAY™ (avacincaptad pegol intravitreal solution) Monthly or Every Other Month Reduced Geographic Atrophy Lesion Growth Through 2 Years
November 3, 2023 | msn.com
ImmunoGen (IMGN) Q3 Earnings Beat, Elahere Drives Revenues
November 1, 2023 | morningstar.com
Oramed Pharmaceuticals Inc ORMP
October 11, 2023 | markets.businessinsider.com
Analyst Ratings for Olema Pharmaceuticals
April 18, 2024 | Paradigm Press (Ad)
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
September 6, 2023 | finance.yahoo.com
EOM Pharmaceutical Holdings Announces Topline Results of its COVID-19 Clinical Trial of EOM613 in Brazil
August 17, 2023 | uk.finance.yahoo.com
Q2 2023 PAVmed Inc Earnings Call
August 3, 2023 | msn.com
EOM Pharmaceuticals shelves plans to uplist shares, raise $15M
July 17, 2023 | benzinga.com
Acumen Pharmaceuticals Announces Proposed Public Offering of Common Stock
July 3, 2023 | marketwatch.com
Amneal Pharmaceuticals: FDA Requests Additional Information on IPX203 Ingredient
June 14, 2023 | marketwatch.com
Amneal Pharmaceuticals Gets FDA Approval for Injectable Tumor Treatment
May 16, 2023 | msn.com
Trade commission fights Amgen's $28B purchase of Horizon Therapeutics
May 10, 2023 | msn.com
Pharma CEOs to testify in U.S. Senate hearing on insulin prices
May 10, 2023 | marketwatch.com
8-K: Acumen Pharmaceuticals, Inc.
May 9, 2023 | msn.com
Olema Pharmaceuticals GAAP EPS of -$0.70 misses by $0.04
May 9, 2023 | investing.com
OliX Pharmaceuticals Inc (226950)
March 30, 2023 | msn.com
USFDA gives final nod to Alembic Pharmaceuticals’ Glaucoma drug
March 27, 2023 | reuters.com
U.S. Supreme Court mulls Amgen bid to revive cholesterol drug patents
March 13, 2023 | marketwatch.com
Regeneron Pharmaceuticals Inc. stock underperforms Monday when compared to competitors despite daily gains
March 11, 2023 | finance.yahoo.com
EOM Pharmaceuticals Holdings, Inc. (IMUC)
February 24, 2023 | seekingalpha.com
Ionis Pharmaceuticals, Inc. (IONS) Q4 2022 Earnings Call Transcript
December 8, 2022 | technews.tmcnet.com
AltruBio Hosting Research & Development Update on Immune Checkpoint Enhancer Platform for T Cell Mediated Immunological Diseases
November 29, 2022 | marketwatch.com
Alaunos Therapeutics Shares Drop 24% After Public Offering Prices
See More Headlines
Receive IMUC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EOM Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/13/2018
Today
4/18/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:IMUC
CUSIP
N/A
CIK
822411
Web
www.imuc.com
Phone
(201) 351-0605
Fax
818-224-5287
Employees
3
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
0.37
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover
10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Dr. Irach B. Taraporewala B.S. (Age 68)
    M.S., Ph.D., CEO, President & Director
    Comp: $265.65k
  • Mr. Wayne I. Danson CPA (Age 70)
    CFO & Treasurer
    Comp: $150k
  • Mr. Eli Goldberger (Age 34)
    Founder, Chairman & COO
  • Dr. Shalom Z. Hirschman M.D. (Age 88)
    Co-Founder, Chief Scientific Officer & Medical Director

Key Competitors

View All Competitors

IMUC Stock Analysis - Frequently Asked Questions

How have IMUC shares performed in 2024?

EOM Pharmaceuticals' stock was trading at $0.2320 at the start of the year. Since then, IMUC stock has decreased by 24.1% and is now trading at $0.1760.
View the best growth stocks for 2024 here.

How were EOM Pharmaceuticals' earnings last quarter?

EOM Pharmaceuticals Holdings, Inc. (OTCMKTS:IMUC) issued its quarterly earnings results on Monday, August, 13th. The company reported ($0.01) EPS for the quarter.

How do I buy shares of EOM Pharmaceuticals?

Shares of IMUC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:IMUC) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
SHOCKING Crypto Leak…
Crypto 101 Media
Biden’s $374B Giveaway Into This Sector
DTI
Biden replacement revealed?
Paradigm Press
The #1 Crypto for 2024
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
How Biden has already won 2024
Porter & Company
Options trading has suddenly become more reliable.
Eagle Publishing